title: Astaxanthin reduces ischemic brain injury in adult rats.
abstract: Astaxanthin (ATX) is a dietary carotenoid of crustaceans and fish that contributes to their coloration. Dietary ATX is important for development and survival of salmonids and crustaceans and has been shown to reduce cardiac ischemic injury in rodents. The purpose of this study was to examine whether ATX can protect against ischemic injury in the mammalian brain. Adult rats were injected intracerebroventricularly with ATX or vehicle prior to a 60-min middle cerebral artery occlusion (MCAo). ATX was present in the infarction area at 70-75 min after onset of MCAo. Treatment with ATX, compared to vehicle, increased locomotor activity in stroke rats and reduced cerebral infarction at 2 d after MCAo. To evaluate the protective mechanisms of ATX against stroke, brain tissues were assayed for free radical damage, apoptosis, and excitoxicity. ATX antagonized ischemia-mediated loss of aconitase activity and reduced glutamate release, lipid peroxidation, translocation of cytochrome c, and TUNEL labeling in the ischemic cortex. ATX did not alter physiological parameters, such as body temperature, brain temperature, cerebral blood flow, blood gases, blood pressure, and pH. Collectively, our data suggest that ATX can reduce ischemia-related injury in brain tissue through the inhibition of oxidative stress, reduction of glutamate release, and antiapoptosis. ATX may be clinically useful for patients vulnerable or prone to ischemic events.
authors.affiliation: National Institute on Drug Abuse, NIH, 251 Bayview Blvd., Baltimore, MD 21224, USA.
authors.forename: Hui
authors.initials: H
authors.lastname: Shen
authors.forename: Chi-Chung
authors.initials: CC
authors.lastname: Kuo
authors.forename: Jenny
authors.initials: J
authors.lastname: Chou
authors.forename: Alice
authors.initials: A
authors.lastname: Delvolve
authors.forename: Shelley N
authors.initials: SN
authors.lastname: Jackson
authors.forename: Jeremy
authors.initials: J
authors.lastname: Post
authors.forename: Amina S
authors.initials: AS
authors.lastname: Woods
authors.forename: Barry J
authors.initials: BJ
authors.lastname: Hoffer
authors.forename: Yun
authors.initials: Y
authors.lastname: Wang
authors.forename: Brandon K
authors.initials: BK
authors.lastname: Harvey
mesh_terms: D000154:Aconitate Hydratase / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001930:Brain Injuries / Q000188:drug therapy* / Q000473:pathology; D002545:Brain Ischemia / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control*; D002560:Cerebrovascular Circulation; D003445:Crustacea; D045304:Cytochromes c / Q000378:metabolism; D004032:Diet; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D020287:In Situ Nick-End Labeling; D015227:Lipid Peroxidation; D008297:Male; D015394:Molecular Structure; D009043:Motor Activity / Q000187:drug effects; D018696:Neuroprotective Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012039:Regional Blood Flow; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D024341:Xanthophylls / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D018696:Neuroprotective Agents; D024341:Xanthophylls; D018698:Glutamic Acid; C005948:astaxanthine; D045304:Cytochromes c; D000154:Aconitate Hydratase